IRF3 and type I interferons fuel a fatal response to myocardial infarction

Kevin R. King(Brigham and Women's Hospital), Aaron D. Aguirre(Harvard University), Yuxiang Ye(Harvard University), Yuan Sun(Harvard University), Jason D. Roh(Harvard University), Richard P Ng(Harvard University), Rainer H. Köhler(Harvard University), Sean P. Arlauckas(Harvard University), Yoshiko Iwamoto(Harvard University), Andrej Savol(Harvard University), Ruslan I. Sadreyev(Harvard University), Mark Kelly(University of Massachusetts Chan Medical School), Timothy P. Fitzgibbons(University of Massachusetts Chan Medical School), Katherine A. Fitzgerald(University of Massachusetts Chan Medical School), Timothy Mitchison(Harvard University), Peter Libby(Brigham and Women's Hospital), Matthias Nahrendorf(Harvard University), Ralph Weissleder(Harvard University)
Nature Medicine
November 6, 2017
10.1038/nm.4428
Cited by 562Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis